|
IRGQ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.470300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.346100E-02 |
| Normal-vs-Stage2 |
3.282300E-02 |
| Normal-vs-Stage3 |
2.191400E-01 |
| Normal-vs-Stage4 |
2.751200E-01 |
| Stage1-vs-Stage2 |
4.744800E-01 |
| Stage1-vs-Stage3 |
6.700200E-01 |
| Stage1-vs-Stage4 |
6.043000E-01 |
| Stage2-vs-Stage3 |
3.516200E-01 |
| Stage2-vs-Stage4 |
3.169200E-01 |
| Stage3-vs-Stage4 |
9.207400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.907900E-02 |
| Normal-vs-AfricanAmerican |
1.192780E-01 |
| Normal-vs-Asian |
1.426170E-02 |
| Caucasian-vs-AfricanAmerican |
8.029200E-01 |
| Caucasian-vs-Asian |
2.916800E-01 |
| AfricanAmerican-vs-Asian |
6.735400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.440100E-02 |
| Normal-vs-Female |
6.866500E-02 |
| Male-vs-Female |
5.462800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.600300E-02 |
| Normal-vs-Age(41-60Yrs) |
8.986400E-02 |
| Normal-vs-Age(61-80Yrs) |
5.294200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.636400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.632200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.092840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.009400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.338800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.735000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.016000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.142000E-03 |
| Classical-VS-Follicular |
1.123960E-03 |
| Classical-VS-Other |
2.141800E-01 |
| Classical-VS-Normal |
1.484110E-03 |
| Tall-VS-Follicular |
8.771200E-01 |
| Tall-VS-Other |
9.942000E-01 |
| Tall-VS-Normal |
8.017800E-01 |
| Follicular-VS-Other |
9.560800E-01 |
| Follicular-VS-Normal |
6.851000E-01 |
| Other-VS-Normal |
8.878000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.147220E-01 |
| Normal-vs-N1 |
7.391000E-01 |
| N0-vs-N1 |
3.544200E-01 |
|
|
